Your browser doesn't support javascript.
loading
Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration.
Boehm, Thomas; Alix, Marion; Petroczi, Karin; Vakal, Serhii; Gludovacz, Elisabeth; Borth, Nicole; Salminen, Tiina A; Jilma, Bernd.
Afiliação
  • Boehm T; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria (T.B., K.P., E.G., B.J.); Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering (M.A., S.V., T.A.S.), and InFLAMES Research Flagship Center (M.A., S.V., T.A.S.), Åbo Akademi University
  • Alix M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria (T.B., K.P., E.G., B.J.); Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering (M.A., S.V., T.A.S.), and InFLAMES Research Flagship Center (M.A., S.V., T.A.S.), Åbo Akademi University
  • Petroczi K; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria (T.B., K.P., E.G., B.J.); Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering (M.A., S.V., T.A.S.), and InFLAMES Research Flagship Center (M.A., S.V., T.A.S.), Åbo Akademi University
  • Vakal S; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria (T.B., K.P., E.G., B.J.); Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering (M.A., S.V., T.A.S.), and InFLAMES Research Flagship Center (M.A., S.V., T.A.S.), Åbo Akademi University
  • Gludovacz E; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria (T.B., K.P., E.G., B.J.); Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering (M.A., S.V., T.A.S.), and InFLAMES Research Flagship Center (M.A., S.V., T.A.S.), Åbo Akademi University
  • Borth N; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria (T.B., K.P., E.G., B.J.); Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering (M.A., S.V., T.A.S.), and InFLAMES Research Flagship Center (M.A., S.V., T.A.S.), Åbo Akademi University
  • Salminen TA; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria (T.B., K.P., E.G., B.J.); Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering (M.A., S.V., T.A.S.), and InFLAMES Research Flagship Center (M.A., S.V., T.A.S.), Åbo Akademi University
  • Jilma B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria (T.B., K.P., E.G., B.J.); Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering (M.A., S.V., T.A.S.), and InFLAMES Research Flagship Center (M.A., S.V., T.A.S.), Åbo Akademi University
J Pharmacol Exp Ther ; 382(2): 113-122, 2022 08.
Article em En | MEDLINE | ID: mdl-35688477
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amina Oxidase (contendo Cobre) / Anafilaxia Limite: Humans Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amina Oxidase (contendo Cobre) / Anafilaxia Limite: Humans Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2022 Tipo de documento: Article